An Epidemic of Dyssynchrony But What Does It Mean? by Kass, David A.
I
n
i
(
g
t
c
a
o
t
t
v
p
m
e
a
s
b
t
d
a
a
p
d
c
e
F
M
I
D
i
w
o
a
Journal of the American College of Cardiology Vol. 51, No. 1, 2008
© 2008 by the American College of Cardiology Foundation ISSN 0735-1097/08/$34.00
PVIEWPOINT AND COMMENTARY
An Epidemic of Dyssynchrony
But What Does It Mean?
David A. Kass, MD
Baltimore, Maryland
Cardiac resynchronization therapy (CRT) is used to treat a subset of heart failure patients with discoordinate wall
motion. Defining appropriate patients is important, and, although electrical delay (wide QRS) is commonly used,
recent data show that measures of mechanical dyssynchrony improve the sensitivity and specificity of predicting
responders (including patients with narrow QRS complexes). This has stimulated studies of dyssynchrony per se,
and the phenomenon now appears to be very common in virtually all forms of heart failure. However, what all
this dyssynchrony means clinically, and how or whether it should be treated by CRT or other means, remains
unclear. (J Am Coll Cardiol 2008;51:12–7) © 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.09.027d
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M
dn the mid 1990s, studies first reported that the simulta-
eous electrical stimulation of right and left ventricles
mproved cardiac function in patients with heart failure
HF) and an intrinsic conduction delay (1–3). At first
lance, it seemed unlikely that this observation would lead
o a clinically significant treatment, yet within the decade
ardiac resynchronization therapy (CRT) was developed
nd confirmed to be beneficial. It soon joined a select group
f treatments that improved HF chamber function, symp-
oms, and mortality (4–6). From the outset, CRT was
argeted to a subset of HF patients who had a delay in
entricular activation as manifested by a wide QRS com-
lex. All of the large clinical CRT trials used a QRS 120
s or longer as a primary entry criteria. However growing
vidence that QRS duration poorly predicted acute (7,8)
nd chronic responses to CRT and that 25% to 30% of
eemingly appropriate patients did not experience clinical
enefit suggested that other parameters might better iden-
ify candidates (9). Mechanical dyssynchrony (i.e., the
isparity in regional contraction timing) was proposed as an
lternative, and early studies found it better correlated with
cute (7) and chronic (10,11) CRT benefit. The latter was
articularly important, because both the magnitude of basal
yssynchrony and its reduction by CRT predicted chronic
hamber functional improvement (12,13) and enhanced
xercise capacity and clinical status (10,11). Furthermore,
rom the Division of Cardiology, Johns Hopkins Medical Institutions, Baltimore,
aryland. Supported by National Health Service (National Heart, Lung, and Blood
nstitute) grant PO1-HL077180 and the Abraham and Virginia Weiss Professorship.
r. Kass is a consultant for Boston Scientific (Natick, Massachusetts), a company
nvolved with cardiac resynchronization devices. The content of this Viewpoint in no
ay presents any intellectual or commercial conflict, because it deals with a question
f pathophysiology and its detection by imaging modalities.n
Manuscript received May 8, 2007; revised manuscript received July 26, 2007,
ccepted September 28, 2007.yssynchrony was found to be an independent predictor of
linical events and worsened survival in HF patients (14,15).
hese findings stimulated the search for new and easier
ays to quantify mechanical dyssynchrony, and over the
ast several years such work has yielded many approaches,
ost based on ultrasound and advanced tissue Doppler
maging methods (16–18).
Given the suspicion that mechanical rather than electrical
yssynchrony would better identify CRT responders, inves-
igators began asking just how prevalent mechanical dyssyn-
hrony was and whether patients suitable for CRT but
ithout QRS widening were being missed. Fueling this
nterest were early studies of HF patients with mechanical
yssynchrony yet a narrow QRS complex that reported
mprovements from chronic CRT (19). Questions were next
aised as to whether dyssynchrony occurred in patients with
F but a preserved ejection fraction (EF) (i.e., 50%), also
ermed diastolic HF. Might they benefit from CRT as well?
ver the past year, reports have started addressing these
uestions, and the results seem to suggest that dyssynchrony
s extraordinarily common in all forms of HF. Indeed, one
ight conclude there is almost an epidemic of dyssyn-
hrony, which a majority of HF patients suffer from and for
hom CRT could be useful. At the same time, these studies
aise important new questions: 1) What is causing the
yssynchrony we observe, and does it all mean the same
hing pathophysiologically; 2) is dyssynchrony always clin-
cally relevant or is some of what we see more of a test result;
nd 3) what should we do about it?
yssynchrony Is Quite Prevalent
ost of the studies assessing dyssynchrony have focused on
ilated HF patients (depressed EF) with either a wide or a
arrow QRS complex. The largest database comes from the
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January 1/8, 2008:12–7 Sorting Out DyssynchronyARE-HF (Cardiac Resynchronization Heart Failure)
tudy, which reported on 735 New York Heart Association
unctional class III or class IV HF subjects with a QRS
uration of 120 ms, and an EF mean of 25.5% (20).
nterventricular dyssynchrony (delay in right vs. left heart
jection based on Doppler flow imaging) was present in
2%. A somewhat higher prevalence (70%) has been
eported in studies using tissue Doppler indexes (21,22). In
atients with a narrow QRS, the incidence appears to be
ower but is still quite substantial, ranging from 30%
21,23,24) in some studies to as much as 50% in others (22).
epending upon how dyssynchrony is defined, however, it
an seem present in virtually all HF patients. In a recent
tudy using cardiac magnetic resonance imaging, investiga-
ors examined dyssynchrony by the standard deviation of
adial motion timing in low EF heart failure patients versus
ontrols (25). Based on having an index 2 normal
ontrol values, HF patients (regardless of QRS duration)
ould be identified with 94% specificity and 100% sensitivity
i.e., all HF patients had at least this amount of dyssyn-
hrony).
More recently, studies have turned to HF patients with a
ormal-range EF. In this group, wide QRS complexes are
are (11% compared with almost 40% in low-EF HF)
26). In a study of 120 HF narrow-QRS complex patients
half with “diastolic HF,” defined as EF 50%, mean
ulmonary capillary wedge pressure 12 mm Hg, and/or
ime constant of LV relaxation 48 ms), Wang et al. (24)
ound systolic dyssynchrony in 30% to 40% and diastolic
yssynchrony in 60% of both HF groups. Dyssynchrony
as assessed by the maximal time difference of peak systolic
ongitudinal velocity or early filling velocity among different
egions in the left ventricle (systolic and diastolic dyssyn-
hrony, respectively). So-called “diastolic dyssynchrony”
ould appear even more common (by 33%) than systolic
yssynchrony (27), although intriguingly, they rarely seem
resent in the same patients. For example, in one recent
tudy of preserved-EF HF patients (26), diastolic dyssyn-
hrony and systolic dyssynchrony were observed in40% of
atients, but were coincident in only 15% of these
ndividuals.
an We Treat It?
ven before studies started showing mechanical dyssyn-
hrony to be quite common, investigators began asking
hether it identified CRT responders even if they had a
arrow QRS complex. Achilli et al. (19) first tested this
ypothesis in 14 patients and found beneficial effects of
RT on clinical and echocardiographic parameters similar
o those in wide-QRS HF patients. This finding was
ecently confirmed by Bleeker et al. (28) and Yu et al. (29),
eporting collectively on 84 patients with systolic dyssyn-
hrony but a narrow QRS and contrasting the results to a
imilar-size group of HF patients with a wide QRS. Both
ound that CRT improved exercise capacity, symptoms, and achocardiographic function re-
ardless of the QRS duration.
ne caveat is that none of these
tudies used a true control group
r was blinded, because all pa-
ients received treatment, and the
ollow-up period was relatively
hort (3 to 6 months). Clinical
lacebo effects, including im-
roved exercise capacity and
ymptoms from CRT, have been
ocumented (5), and, although
his may or may not apply to image-based assessments, bias
s difficult to fully exclude when the therapy is known.
These studies targeted patients with “systolic dyssyn-
hrony” and a low EF. In this situation, one can link the 2
ehaviors, because studies in animals and humans have
hown that systolic dyssynchrony impairs net systolic func-
ion. But what about patients where EF is50% or in those
ith only diastolic dyssynchrony; would they also respond to
RT? Can you have clinically relevant systolic dyssynchrony
ith a normal EF? When dyssynchrony is induced by
ingle-site pacing (or left bundle branch block [LBBB]),
hen cardiac function declines regardless of the initial EF. In
study we performed testing acute RV apical stimulation in
ubjects with HF due to hypertensive cardiac hypertrophy,
acing-induced dyssynchrony lowered EF from 78% to 65%
nd dP/dtmax from 1,767 mm Hg/s to 1,522 mm Hg/s
15%) (30). However, in treating these patients chroni-
ally, pacing-induced dyssynchrony (VDD mode) improved
ardiac function by helping to prevent cavity obliteration
nd restoring cardiac reserve and thus improving HF
ymptoms (31). Some have argued that this syndrome has a
omponent of systolic dysfunction, as indexed by systolic
ongitudinal tissue Doppler velocities (32), so perhaps one
hould try to improve it. However, this parameter can reflect
hamber geometry and loading and is similarly reduced in
ypertensive-hypertrophy patients without HF symptoms
33). Moreover, measurements based on more direct inva-
ive data have found similar (34) or enhanced (35) systolic
unction in these patients. Therefore, whether a treatment
hat improved systolic function would help symptoms in
his population is unclear. What if you have only diastolic
yssynchrony: Can you pace the heart to fix it? As yet, CRT
oes not appear to affect diastolic dyssynchrony, at least as
t has been clinically defined using tissue Doppler (27).
s soon as you apply an electrical stimulation you
rimarily influence the timing of systole and secondarily
hat of diastole. It is hard to fathom how pacing could
lter timing delays only in early diastole. Biventricular is
etter than single-site pacing with respect to systolic
unction but not necessarily better than normal conduc-
ion, so one might end up compromising one part of the
ycle to target another.
Recent evidence also indicates that the dyssynchrony we
Abbreviations
and Acronyms
CRT  cardiac
resynchronization therapy
EF  ejection fraction
HF  heart failure
LBBB  left bundle branch
block
LV  left ventricular
RV  right ventricularre observing can be treated medically, raising further
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Sorting Out Dyssynchrony January 1/8, 2008:12–7uestions about its causes. Diastolic dyssynchrony was
ound to correlate with prolonged relaxation and elevated
stimated mean pulmonary capillary wedge pressure (24),
nd both changed in tandem with various drug treatments
diuretics, angiotensin-converting enzyme inhibitors, angio-
ensin type-1 receptor, or calcium-channel blockers) that
owered blood pressure in preserved-EF HF patients (24).
ystolic dyssynchrony may also be ameliorable to drug
reatment; a recent study of HF patients with a narrow QRS
ound that carvedilol reduced systolic dyssynchrony (36).
hat Are We Measuring?
onfronted with so much dyssynchrony, it is appropriate to
onsider what one is measuring and why it might occur. All
f the studies have examined wall motion, either deforma-
ion or its velocity, but this does not clarify whether the
ause is a delay in electrical activation or the result of
eterogeneity of contractile properties in the wall. The
ormer is more easily appreciated as a likely target for an
lectrical pacemaker therapy such as CRT, whereas for the
atter the case is less clear. The left panel of Figure 1 shows
model of how delay in muscle activation of one region
elative to another results in dyssynchrony. This would be
he classic model with a wide QRS, as generated by an
BBB or single-site pacing. Myocardial activation is mod-
led by a ventricular time-varying elastance (myocardial
tiffening), and one curve (lateral wall) is phase delayed
Figure 1 Schematic of Different Mechanisms
for Generating Cardiac Dyssynchrony
Muscle activation is depicted by myocardial elastance (stiffening). In the exam-
ple with a temporal delay (left panel), both regions of the heart contract with
similar force (contractility) but one has a phase delay relative to the other. The
vertical difference between curves determines when one area of muscle is
stiffer than the other and thus when reciprocal wall contraction and stretch
(dyssynchrony) will be observed. This rises early during isovolumic contraction
and peaks at end-systole/early diastole. This can be treated by cardiac resyn-
chronization therapy (CRT). The right panel shows an example where the 2
regions of the heart are stimulated at the same time but there is a disparity in
contractility, so one territory is stronger the other another. As muscle activation
progresses, there will also be dyssynchrony, because the stronger wall pushes
out the weaker one, and in early relaxation the weaker wall now appears to
contract. This is typical of ischemic heart disease. The vertical difference
between curves again identifies the discoordinate wall motion (i.e., dyssyn-
chrony) that would be observed (based on times when maximal regional short-
ening is observed around the heart, or the variance in its magnitude). However,
this dyssynchrony is probably not amenable to a pacing (i.e., CRT) strategy.gelative to the other. When one wall is stiffer than the other,
t stretches the alternate wall, generating dyssynchrony. The
ifference curve shown in Figure 1 depicts this dyssynchrony
hich rises during early isovolumic contraction (underlying
hy dP/dtmax is so sensitive as an index) and peaks at
nd-systole/early relaxation. The latter explains why systolic
yssynchrony is often assessed at or near aortic valve closure
nd why postsystolic motion is frequently observed. Elec-
rically phase-advancing one region relative to the other will
esolve this problem.
It is a bit difficult to imagine how this behavior can occur
ithout any demonstrable electrical delay (i.e., narrow
RS), if indeed a large portion of the wall is contracting
uch later than another. One possibility is that right heart
ctivation is so quick that left ventricular dyssynchrony still
ields a narrow electrical complex. Alternatively, one might
ave abnormal excitation-contraction coupling altering the
inetics of force development in one part of the heart
ompared with another. How often either occurs is unclear.
erhaps a more likely explanation is that the dyssynchrony
s not related to electrical timing but more to regional
isparities in contractility. For example, what happens if a
egion of the wall is weaker, perhaps owing to ischemic
amage or chronic hypoperfusion, heterogeneity of neural/
ormonal stimulation, or fibrosis. This is depicted in the
ight panel of Figure 1. Here, activation occurs simulta-
eously, but one part of the wall contracts more strongly
han the other. One will again see discoordinate motion as
he strong pushes out the weaker wall and the latter
ontracts in early diastole. However, it is far less clear how
ltering electrical stimulation will treat this. This condition
s more difficult to diagnose, because practical methods to
etermine regional myocardial contractility remain lacking.
owever, perhaps by combining mechanical imaging with
-dimensional electrical analyses (37), one might better
eveal the substrate.
Regardless of the precise mechanism, the apparent suc-
esses of several smaller tirals of CRT for treating narrow
omplex QRS HF subjects (19,28,29) supports some ben-
fit. If the problem is simply electrical delay, perhaps having
heart in which the lateral wall contracts late is worse than
aving it contract sooner. Early contraction could unload
he lateral wall so it developed less stress and perhaps less
hronic adverse remodeling. These results have been ques-
ioned by a larger randomized and controlled trial (Re-
hinQ ; Cardiac Resynchronization Therapy in Patients
ith Heart Failure and Narrow QRS) (38). This study
eported no benefit from CRT on the primary end point
increase in peak oxygen consumption of at least 1.0
l/kg/min after 6 months) or in the number of HF events
equiring intravenous treatment for patients with a QRS
nterval 120 ms. Differences in how mechanical dyssyn-
hrony was indexed between studies may have played some
ole, but the latter study importantly included a control
roup.
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January 1/8, 2008:12–7 Sorting Out DyssynchronyThe issue raised by the presence or lack of concurrence of
ystolic and diastolic dyssynchrony in the same patient deserves
omment. Some studies have found that everyone with systolic
yssynchrony has it in diastole as well, although diastolic
yssynchrony can also occur alone (24). Others find very little
oncurrence of the 2 behaviors (26). Figure 2 shows data
rom the first study to depict the full temporal course of
yssynchrony evolution and resolution in a failing heart with
n LBBB. The plot is based on magnetic resonance tagged
maging of a dog with the dyssynchrony index obtained
rom 3-dimensional circumferential strain maps. Dyssyn-
hrony evolves gradually during systole, peaks near end-
ystole, and then declines. When induced by a conduction
elay (the same findings are obtained with a right ventric-
lar pacemaker), it is impossible to dissociate increased
ispersion of strain values or timing during systole (i.e.,
ystolic dyssynchrony) from that during early diastole (dia-
tolic dyssynchrony). As shown in Figure 2, application of
RT affects both and could not likely be targeted to diastole
lone. Dissociation of systolic and diastolic behaviors is less
urprising if it were due to regional heterogeneity of
yocardial function, loading, and so on, that can differen-
ially impact portions of the cardiac cycle. Experimental
tudies have previously shown that increasing arterial after-
oad, and particularly imposing this load late in systole, as
ccurs in older patients with stiffer arteries, results in
egional discoordinate motion (39,40). Furthermore, this
yssynchrony correlates with relaxation delay (41). The
atter has also been observed in isolated muscle and in hearts
ith systolic loading imposed (42). Those studies were
erformed using normal hearts, but load-induced dyssyn-
Figure 2 Measured Time Course of LV Dyssynchrony and its
Recovery in an Animal Model of Dilated HF and a LBBB
Dyssynchrony is assessed using 3-dimensional circumferential strains, calculat-
ing a vector sum index that not only provides information about the dispersion
of strain values during the heart beat but further amplifies this if they are geo-
graphically clustered (i.e., the whole lateral wall is late) (45). Dyssynchrony gradu-
ally rises to end-systole and then declines, so dyssynchrony during systole and
diastole would be observed. Biventricular pacing (cardiac resynchronization ther-
apy) reduces dyssynchrony during both periods. HF  heart failure; LBBB  left
bundle branch block; LV  left ventricular.hrony is probably greater in chronically failing ventricles, mecause load-induced relaxation delay is also greater. Simply
ut, the heart is not a homogeneous material nor is it
ymmetric, so changes in global loading can differentially
ffect regional loading and thus the timing of local contrac-
ion and relaxation as observed by wall motion. The fact that
ntihypertensive therapy or beta-blockade can improve dys-
ynchrony in failing hearts speaks to such interactions and
echanisms.
Lastly, it is important to comment on the limitations of
ow dyssynchrony is being assessed. For one, we have now
eveloped sensitive imaging tools, but these are susceptible
o user variability of both image acquisition and analysis,
nd this may limit the reliability of the results. Derivation of
hese indexes often requires some subjective assessment of
hich peaks reflect which motion, and this is not always
traightforward to interpret. Few, if any, studies have
xamined repeated assessments of dyssynchrony made by
ifferent operators blinded to the prior measurements, with
he variance then determined. Cause for concern was
ighlighted recently by the PROSPECT (Predictors of
esponse to Cardiac Resynchronization Therapy) trial (43)
hose preliminary results were reported at the European
ardiology Society Meeting in September, 2007 (44). This
ulticenter trial of 426 patients receiving CRT involved
ore than 50 centers throughout Europe, Asia, and North
merica and examined the reproducibility and predictive
alue (response to CRT) of many echo and tissue Doppler
maging indexes of dyssynchrony. Each center had received
pecific training regarding imaging methods—with a clear
ffort to enhance uniformity of approach, and the data were
nterpreted by 3 blinded core laboratories, one on each
ontinent. There was marked variability in the analysis
erived from the identical images among the core centers,
nd while some indexes did correlate with CRT response,
heir sensitivity and specificity was fairly poor. Clearly, more
ork is needed to achieve an adequately robust and appli-
able approach to this analysis.
Another factor may be the methods used to quantify
yssynchrony. Most are based on maximal temporal delay or
ariance of time delays, which do not imply that a substan-
ial contiguous region of the wall is out of synchrony, such
s is generated with a single-site pacemaker. Dispersed
elays in contractile/relaxation timing due to heterogeneity
f a failing heart may contribute to the disease but be no
ore specific to any pathway or potential therapy than other
arkers of dysfunction. They would seem unlikely to be
enefited by electrical treatment such as CRT. A dyssyn-
hrony index based on peak difference or variance in such
elays does not differentiate this situation from one where
ndeed a whole side of the heart wall contracts late. There
re ways, however, that have been described where by a
yssynchrony index is derived that takes this geographic
ispersion into account (45). I would propose more of these
ypes of indexes be considered, regardless of the primary
easurements employed. Perhaps this may help define
w
t
N
W
w
t
i
c
t
m
c
a
n
w
b
n
l
s
m
b
t
R
D
B
E
R
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
3
3
16 Kass JACC Vol. 51, No. 1, 2008
Sorting Out Dyssynchrony January 1/8, 2008:12–7hat types of dyssynchrony are amenable to what type of
reatment.
ow What?
henever a new methodology evolves that provides a new
indow into the function of the heart, it can reveal behavior
hat we have not previously appreciated. To an extent, the
nitial appearance of Doppler flow imaging revealed a fairly
ommon incidence of mitral regurgitation, and it took some
ime to clarify what was and what was not clinically
eaningful. Whether we are at a similar point with dyssyn-
hrony, which is admittedly not normal but very common in
ll sorts of HF, remains to be seen. One worry is that we will
ow develop a new class of CRT nonresponders, patients
ith apparent mechanical dyssynchrony that is not amena-
le to CRT. We need to remember that HF is a heteroge-
eous disease, and, combined with abnormal hormone and
oading stimulation, one often sees the wall moving out of
ynchrony. As we find various forms of dyssynchrony in
ore and more patients with HF, we should consider the
roader pathophysiology to help determine what, if any-
hing, should be done about it in specific patients.
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